Publication Cover
Amyloid
The Journal of Protein Folding Disorders
Volume 17, 2010 - Issue 2
285
Views
34
CrossRef citations to date
0
Altmetric
Original Article

Suppression of choroid plexus transthyretin levels by antisense oligonucleotide treatment

, , , , , & show all
Pages 43-49 | Published online: 12 May 2010

References

  • Benson MD, Kincaid JC. The molecular biology and clinical features of amyloid neuropathy. Muscle Nerve 2007;36:411–423.
  • Benson MD. Amyloidosis and other protein deposition diseases. In: Rimoin DL, Connor JM, Pyeritz RE, Korf BR, editors. Emery and Rimoin's principles and practice of medical genetics. 5th ed., Vol. 2, Chapter 83. Churchill Livingstone publishers; 2005. pp. 1821–1834.
  • Martone RL, Herbert J, Dwork A, Schon EA. Transthyretin is synthesized in the mammalian eye. Biochem Biophys Res Commun 1988;151:905–912.
  • Brett M, Persey MR, Reilly MM, Revesz T, Booth DR, Booth SE, Hawkins PN, Pepys MB, Morgan-Hughes JA. Transthyretin Leu12Pro is associated with systemic, neuropathic and leptomeningeal amyloidosis. Brain 1999;122:183–190.
  • Garzuly F, Vidal R, Wisniewski T, Brittig F, Budka H. Familial meningocerebro-vascular amyloidosis, Hungarian type, with mutant transthyretin (TTR Asp18Gly). Neurology 1996;47:1562–1567.
  • Vidal R, Garzuly F, Budka H, Lalowski M, Linke RP, Brittig F, Frangione B, Wisniewski T. Meningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon 18 (TTR D18G). Am J Pathol 1996;148:361–366.
  • Sekijima Y, Hammarström P, Matsumura M, Shimizu Y, Iwata M, Tokuda T, Ikeda S, Kelly JW. Energetic characteristics of the new transthyretin variant A25T may explain its atypical central nervous system pathology. Lab Invest 2003;83:409–417.
  • Shimizu Y, Takeuchi M, Matsumura M, Tokuda T, Iwata M. A case of biopsy-proven leptomeningeal amyloidosis and intravenous Ig-responsive polyneuropathy associated with the Ala25Thr transthyretin gene mutation. Amyloid 2006;13:37–41.
  • Herrick MK, DeBruyne K, Horoupian DS, Skare J, Vanefsky MA, Ong T. Massive leptomeningeal amyloidosis associated with a Val30Met transthyretin gene. Neurology 1996;47:988–992.
  • Goren H, Steinberg MC, Farboody GH. Familial oculoleptomeningeal amyloidosis. Brain 1980;103:473–495.
  • Petersen RB, Goren H, Cohen M, Richardson SL, Tresser N, Lynn A, Gali M, Estes M, Gambetti P. Transthyretin amyloidosis: a new mutation associated with dementia. Ann Neurol 1997;41:307–313.
  • Mascalchi M, Salvi F, Pirini MG, D'Errico A, Ferlini A, Lolli F, Plasmati R, Tessa C, Villari N, Tassinari CA. Transthyretin amyloidosis and superficial siderosis of the CNS. Neurology 1999;53:1498–1503.
  • Nakagawa K, Sheikh SI, Snuderl M, Frosch MP, Greenberg SM. A new Thr49Pro transthyretin gene mutation associated with leptomeningeal amyloidosis. J Neurol Sci 2008;272:186–190.
  • Ellie E, Camou F, Vital A, Rummens C, Grateau G, Delpech M, Valleix S. Recurrent subarachnoid hemorrhage associated with a new transthyretin variant (Gly53Glu). Neurology 2001;57:135–137.
  • Uemichi T, Uitti RJ, Koeppen AH, Donat JR, Benson MD. Oculoleptomeningeal amyloidosis associated with a new transthyretin variant Ser64. Arch Neurol 1999;56:1152–1155.
  • Blevins G, Macaulay R, Harder S, Fladeland D, Yamashita T, Yazaki M, Hamidi Asl K, Benson MD, Donat JR. Oculoleptomeningeal amyloidosis in a large kindred with a new transthyretin variant Tyr69His. Neurology 2003;60:1625–1630.
  • Ueno S, Uemichi T, Yorifuji S, Tarui S. A novel variant of transthyretin (Tyr114 to Cys) deduced from the nucleotide sequences of gene fragments from familial amyloidotic polyneuropathy in Japanese sibling cases. Biochem Biophys Res Commun 1990;169:143–147.
  • Southwell BR, Duan W, Alcorn D, Brack C, Richardson SJ, Köhrle J, Schreiber G. Thyroxine transport to the brain: role of protein synthesis by the choroid plexus. Endocrinology 1993;133:2116–2126.
  • Motojima K, Goto S. Brain-specific expression of transthyretin mRNA as revealed by cDNA cloning from brain. FEBS Lett 1989;258:103–105.
  • Mitsuhashi S, Yazaki M, Tokuda T, Sekijima Y, Washimi Y, Shimizu Y, Ando Y, Benson MD, Ikeda S. Biochemical characteristics of variant transthyretins causing hereditary leptomeningeal amyloidosis. Amyloid 2005;12:216–225.
  • Terazaki H, Ando Y, Nakamura M, Obayashi K, Misumi S, Shoji S, Yamashita S, Nakagawa K, Ishizaki T, Suhr O, et al Variant transthyretin in blood circulation can transverse the blood-cerebrospinal barrier: qualitative analyses of transthyretin metabolism in sequential liver transplantation. Transplantation 2001;72:296–299.
  • Benson MD. Leptomeningeal amyloid and variant transthyretins. Am J Pathol 1996;148:351–354.
  • Said G, Planté-Bordeneuve V. Familial amyloid polyneuropathy a clinico-pathologic study. J Neurol Sci 2009;284:149–154.
  • Benson MD, Kluve-Beckerman B, Zeldenrust SR, Siesky AM, Bodenmiller DM, Showalter AD, Sloop KW. Targeted suppression of an amyloidogenic transthyretin with antisense oligonucleotides. Muscle Nerve 2006;33:609–618.
  • Cossum PA, Sasmor H, Dellinger D, Truong L, Cummins L, Owens SR, Markham PM, Shea JP, Crooke S. Disposition of the 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats. J Pharm Sci Exp Ther 1993;267:1181–1190.
  • Smith RA, Miller TM, Yamanaka K, Monia BP, Condon TP, Hung G, Lobsiger CS, Ward CM, McAlonis-Downes M, Wei H, et al Antisense oligonucleotide therapy for neuro-degenerative disease. J Clin Invest 2006;116:2290–2296.
  • Holmgren G, Steen L, Ekstedt J, Groth C-G, Ericzon B-G, Eriksson S, Andersen O, Karlberg I, Nordén G, Nakazato M, et al Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30). Clin Genet 1991;40:242–246.
  • Liepnieks JJ, Benson MD. Progression of cardiac amyloid deposition in hereditary transthyretin amyloidosis patients after liver transplantation. Amyloid 2007;14:277–282.
  • Munar-Qués M, Salva-Ladaria L, Mulet-Perera P, Solé M, López-Andreu FR, Saraviva JM. Vitreous amyloidosis after liver transplantation in patients with familial amyloid polyneuroapthy: ocular synthesis of mutant transthyretin. Amyloid Int J Exp Clin Invest 2000;7:266–269.
  • Ando Y, Terazaki H, Nakamura M, Ando E, Haraoka K, Yamashita T, Ueda M, Hirano K, Yamada M, Matsumoto K, et al A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation. Transplantation 2004;77:345–349.
  • Yamashita T, Ando Y, Ueda M, Nakamura M, Okamoto S, Zeledon ME, Hirahara T, Hirai T, Ueda A, Misumi Y, et al Effect of liver transplantation on transthyretin Tyr114Cys-related cerebral amyloid angiopathy. Neurology 2008;70:123–128.
  • Dickson PW, Aldred AR, Marley PD, Guo-Fen T, Howlett GJ, Schreiber G. High prealbumin and transferrin mRNA levels in the choroid plexus of rat brain. Biochem Biophys Res Commun 1985;127:890–895.
  • Herbert J, Wilcox JN, Pham K-TC, Fremeau RT Jr, Zeviani M, Dwork A, Soprano DR, Makover A, Goodman DS, Zimmerman EA, et al Transthyretin: a choroid plexus-specific transport protein in human brain. Neurology 1986;36:900–911.
  • Li ZS, Dziegielewski KM, Saunders NR. Transthyretin distribution in the developing choroid plexus of the South American opossum (Monodelphis domestica). Cell Tissue Res 1997;287:621–624.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.